Establishing the role of the MiniMed™ 780G system in the treatment of type 1 diabetes: world-wide experience

Medtronic International Trading Sàrl |
Tuesday

Chairs: Olga Kordonouri (GER), Ohad Cohen (ISR)

07:45 – 07:51Moving towards new glycemic treatment goals (TITR) for young people with type 1 diabetes: insights from the SWEET registryOlga Kordonouri (GER)
07:51 – 08:01Insights from real-world evidence in glycemic metrics: something new, something oldOhad Cohen (ISR)
08:01 – 08:11Expanding the access to MiniMed 780G on a national level: the UK experiencePartha Kar (UK)
08:11 – 08:19Consistent real-world experience with MiniMed™ 780G system around the world: What happens during the Ramadan?Mohammed Al-Sofiani (SAU)
08:19 – 08:27Consistent real-world experience with MiniMed™ 780G system around the world: Results in IndiaV. Mohan (IND)
08:27 – 08:35Consistent real-world experience with MiniMed™ 780G system around the world: Results in Latin AmericaBruno Grassi (CHL)
08:35 – 08:45Questions & AnswersOlga Kordonouri (GER)